GLMD

NASDAQ · Biotechnology

Galmed Pharmaceuticals Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.66

+0.06 (+10.62%)

As of May 16, 2:35 AM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +2,519.6% upside

Low Target $9.83

Average Target $17.25

High Target $23.67

Current Price $0.66

Current
$0.66

Target
$17.25

$9.83 $17.25 avg $23.67

Scenario Analysis

Bear Case

$9.83

1,392.8%

Low target

Base Case

$17.25

+2,519.6%

Avg target

Bull Case

$23.67

+3,494.5%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$2.34

-71.9% from high

52-Week Low

$0.41

+60.2% from low

Target vs 52W High

$17.25

+637.2% vs high

Next Earnings Report

May 20, 2026

until earnings

EPS Est: $-0.39

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%